Exosome CDMO

Exosome CDMO

Exosome CDMOExosome CDMO
Exosome CDMO

Service Overview | Exosomes – A New Technology in Regenerative Medicine

 

Exosomes are nano-sized vesicles secreted by cells. According to scientific literature, exosomes can regulate inflammatory responses, promote angiogenesis and neural repair, activate cells, and support tissue regeneration. Studies also suggest that stem cell-derived exosomes hold significant potential for clinical applications, positioning them as a promising emerging product in the regenerative medicine market with the potential to address currently unmet medical needs.

 

GWOXI ensures the quality of exosome production by rigorously selecting cell sources and employing proprietary patented technology to stimulate high-yield exosome secretion enriched with bioactive substances. The exosomes undergo professional isolation and purification, aseptic filling in clinical-grade environments, and comprehensive testing for bioactivity and quality. These tests include Nanoparticle Tracking Analysis (NTA), biomarker profiling, protein concentration measurement, growth factor quantification, source cell quality identification, and sterility testing. All processes are designed to meet the gold standards of exosome characterization, helping accelerate your exosome product development and research applications.


Service Advantages | Strict Quality Control from Source to Delivery

 

Manufactured to High-Quality Clinical Standards

    • The cell bank and manufacturing facilities comply with clinical-grade standards.
    • Cell sources are rigorously selected and undergo comprehensive quality testing.

 

Rigorous purification techniques and testing procedures

    • Backed by rich clinical experience and in-depth expertise in critical proprietary processes
    • Proprietary patented technology and conditioned culture media enable the collection of high-quality exosomes.
    • We provide comprehensive safety and functional evaluation reports of exosomes based on the ISEV guidelines.

 

We support delivery tailored to a variety of application requirements.

    • Available for product development in clinical applications, medical aesthetics, and skincare.
    • We offer products in sterile laser-sealed vials, sterile empty vials, liquid formulations, and lyophilized (freeze-dried) forms to meet diverse needs. 

 

提Providing a comprehensive one-stop production solution(One-Stop Service)

    • We provide streamlined exosome CDMO/CMO services encompassing raw material development, formulation optimization, packaging design, and product education and training.

 

Certified to meet international standards for cosmetic ingredients.(INCI Name)

GWOXI’s “Human Adipose-Derived Mesenchymal Stem Cell Exosomes” have received INCI New Ingredient Certification.
GWOXI’s "Human Adipose-Derived Mesenchymal Stem Cell Exosomes" have been granted INCI New Ingredient Certification.

Contract Manufacturing Process

 

1. Inquiry
Assess requirements and expected applications to offer guidance on cell sourcing and production yield planning. 
 

2. Provide standard pricing proposals or formalize the engagement through contract agreements.
The parties finalize specifications and delivery terms, followed by signing the partnership agreement.
  

3. Culturing and Exosome Collection
Cells are prepared and expanded in culture following designated specifications.
  

4. Exosome Purification and Analytical Testing
Perform purification and concentration procedures, along with comprehensive quality assessments.
  

5. Deliver products along with comprehensive testing reports.
Products are delivered per client specifications, with testing reports included.

 

GWOXI Exosome CDMO Services

 

For more information on partnership opportunities or pricing plans, kindly contact us.

FAQ
FAQ
FAQ
  • How to determine the quality of exosomes?

    Exosomes demonstrate tremendous potential in cellular communication and regulation of biological activity. In particular, stem cell-derived exosomes have become a focal point in regenerative medicine and the biotech industry.

    However, with the explosive growth of related products in the market, we must raise an important question:Are you really using genuine exosomes?

    Purification TechnologyPurification technology is the core key to ensuring exosome quality. Since cell culture supernatants contain a variety of particles of different sizes and functions—such as cell debris, proteins, and other extracellular vesicles—only through rigorous purification processes can genuine exosomes be effectively isolated while preserving their integrity and functionality.

    At presentPublished by the International Society for Extracellular Vesicles《MISEV2023》Aiming to provide detailed guidelines for the purification and analysis of exosome research:

    • Employ a multi-step purification process
    • Select purification techniques based on sample characteristics
    • Filtration or column chromatography is recommended to enhance purity.
    • Standardization and Transparency of Purification Methods

     

    Even with highly efficient purification techniques, it is impossible to guarantee the consistent isolation of pure exosomes every time. At this point,Identification TechniquesThey become essential tools for confirming the authenticity of purified exosome products.

    • Characterization and identification using multiple analytical techniques
    • Use control groups to verify the accuracy of results
    • Provide comprehensive data presentation, including particle size distribution graphs, quantitative marker data, and content analysis.

     

    Only through rigorous purification and precise identification techniques can the quality and safety of exosomes be ensured. For clinical-grade exosomes, in addition to meeting clinical standards, the source of clinical-grade cells is equally critical, along with identification methods that confirm exosome characteristics and functionality.

     Exosome Purification and Analytical Techniques: Guidelines Based on MISEV2023

     

    GWOXI stem cells possess an exclusive exosome technology platform. In addition to having a cell bank and manufacturing facilities that meet clinical-grade standards, we provide comprehensive safety and functional testing of exosomes to ensure the purity and stability of exosome products, fully meeting clients’ contract manufacturing needs.

  • What are exosomes? Can they delay aging?

    Feeling weak knees during outings? Experiencing numbness in your hands or feet after staying in the same position too long? Is your sleep quality worsening as you age? Noticing fine lines under your eyes and dull skin tone, with a growing sense of fatigue?

    These signs indicate that our bodies are aging. Maintaining health and slowing down aging are goals we all aspire to. With advances in medical technology and skincare, delaying aging is no longer an unattainable dream! Recently, exosomes have become a rising star in the field of anti-aging.

    Exosomes are an emerging medical technology making waves in clinical medicine, aesthetics, cosmetics, and even anti-aging research. But what exactly are exosomes? How did they rise from obscurity to become a new choice in the medical field? This article will take you on a journey to explore the true value of exosomes.

     

    1. What are exosomes?

     

    The following summarizes the exosome research guidelines based on the International Society for Extracellular Vesicles’ (ISEV) MISEV2023 recommendations.

    • exosomesExosomes are a subtype of extracellular vesicles (EVs).,Exosomes are nanoscale vesicles, ranging from 30 to 150 nm, secreted by cells.
    • Exosomes possess a bilayer phospholipid membrane structure similar to the cell membrane. They are taken up by recipient cells through mechanisms such as fusion, endocytosis, and receptor-mediated interactions, enabling efficient intercellular communication. The signaling molecules carried by exosomes participate in various physiological and pathological processes between cells.
    • The signaling molecules within exosomes include proteins, nucleic acids, cytokines, and various growth factors.
    • All cells secrete exosomes, with those derived from humans, animals, and plants being the most common. Among these, exosomes secreted by human stem cells are the most widely studied and well-known in research.
    • Exosomes can be collected from a wide range of sources, including tissues, cerebrospinal fluid, urine, blood, saliva, and cell culture media. The cargo carried by exosomes varies depending on their origin. Additionally, differences in purification techniques can affect the purity, contaminants, allergenicity, safety, and efficacy of the exosome preparations.
    • Therefore, when choosing exosomes, consider asking these three questions: What is the cellular source of the exosomes? Is there sufficient evidence supporting their safety and efficacy? Are they truly genuine exosomes?

     

    (Further Understanding:Exosome Purification and Analysis Techniques According to MISEV2023 Recommendations)

     

    2. Diverse Applications of Exosomes

     

    • Cosmetics:Exosomes are gaining increasing attention in the cosmetics field, particularly in skin repair and anti-aging skincare products, where they have become an indispensable key ingredient. Containing various growth factors, proteins, and lipids, exosomes effectively nourish skin cells, promote collagen synthesis and skin regeneration, and provide antioxidant and anti-inflammatory benefits. Moreover, due to their small molecular size and high permeability, exosomes are more readily absorbed by the skin, allowing their encapsulated active ingredients to penetrate deeply and exert their effects. This has made exosomes a star ingredient in the cosmetics industry in recent years. (Further Understanding:Are exosome-based cosmetics legal?)

     

    • Aesthetic medicine:In the field of aesthetic medicine, numerous studies have shown that stem cell-derived exosomes possess anti-inflammatory, immunomodulatory, antioxidant, and cell proliferation-promoting properties. Research also indicates their potential in accelerating skin repair and improving scarring. As a result, they hold great promise for use in treatments aimed at scar reduction, fine line improvement, and overall skin rejuvenation. (Further Understanding:Exosome technology is driving a new trend in aesthetic medicine.)

     

    • Medical technology:The application of exosomes in medical technology spans regenerative medicine, cancer therapy, and immunomodulation. In regenerative medicine, exosomes are regarded as a vital extension of stem cell therapy, capable of delivering key biological signals to support the repair of damaged tissues. In the field of cancer research, exosomes are used as carriers for targeted drug delivery, enabling therapeutic molecules to reach cancer cells with high precision and thereby enhancing treatment efficacy. Additionally, the potential of exosomes in immunomodulation has gained increasing attention, as they can regulate immune responses and reduce inflammation.

     

    3. A New Choice in Medical Care---Mesenchymal Stem Cell-Derived Exosomes

     

    Among the many sources of exosomes, mesenchymal stem cell-derived exosomes have emerged as a promising new option for disease treatment and regenerative medicine, thanks to their natural repair and regenerative capabilities, as well as their low immunogenicity.

    • Mesenchymal Stem CellsMesenchymal stem cells possess regenerative, reparative, and homing abilities,with their therapeutic potential demonstrated in clinical (and preclinical) trials for multiple indications, including neurodegenerative diseases, cardiovascular regeneration, and tissue repair.
    • Exosomes secreted by mesenchymal stem cells have been found to aid tissue repair and regeneration, regulate the immune system, suppress inflammatory responses, and promote wound healing.
    • By modulating immune responses, promoting cell proliferation and regeneration, improving the microenvironment, and enhancing tissue repair, exosomes are considered to have potential therapeutic effects for various indications.
    • Exosomes are nanoscale particles that can cross the blood-brain barrier (BBB), making them highly promising for brain-based therapies.
    • Purified mesenchymal stem cell-derived exosomes exhibit high safety and compatibility, with a low risk of triggering immune reactions or other adverse effects.

     

    Exosomes have multiple sources, and those derived from carefully reviewed stem cell sources, combined with rigorous clinical preparation standards and supporting documentation, undergo thorough verification. Only after such validation can stem cell-derived exosomes ensure both safety and efficacy, making them a promising new option for clinical medical treatments.

     

    References

    • Welsh, Joshua A et al. “Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.” Journal of extracellular vesiclesvol. 13,2 (2024): e12404. doi:10.1002/jev2.12404
    • Byung-Chul Lee et al. “Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes” J Clin Med. 2021 Feb 11;10(4):711. doi: 10.3390/jcm10040711.
    • Bhushan N Kharbikar et al. “Biomaterials to enhance stem cell transplantation” Cell Stem Cell. 2022 Apr 27;29(5):692–721. doi: 10.1016/j.stem.2022.04.002
  • Can stem cell-derived exosomes also be used as ingredients in cosmetics?

    INCI Name What is it?

    INCI Name is International Nomenclature Cosmetic Ingredients (INCI).This refers to the International Nomenclature of Cosmetic Ingredients (INCI), which has established a standardized naming system for cosmetic ingredients since its founding in 1973. The naming system is developed by the International Nomenclature Committee (INC) and published by the Personal Care Products Council (PCPC) in the "International Cosmetic Ingredient Dictionary and Handbook." It serves as a trusted resource for the cosmetics industry and scientists, and further helps protect consumer rights.

      

    Can stem cell-derived exosomes also be used as ingredients in cosmetics?

    Currently, several biotechnology companies worldwide have had their stem cell-derived exosomes approved and certified through the INCI Name review. It is important to note, however, that the manufacturing processes of these exosomes differ to some extent between companies. Before market launch, the products must undergo safety evaluations and comply with local cosmetic registration and regulatory requirements. According to the literature, stem cell-derived exosomes possess various potential benefits, including promoting wound healing and skin regeneration, alleviating inflammation, and stimulating hair growth. Consumers must first understand the source of exosomes and other factors that may influence their effectiveness, such as species (human, plant, animal), cell source (tissue, extract), manufacturing conditions, patented processes, experimental data, test reports, and third-party verification. Additionally, the concentration of exosomes can affect their therapeutic effects. Therefore, when selecting related products, consumers should pay attention to this information to better safeguard their rights.

      

    GWOXI stem cell-derived exosomes have been certified. INCI Name Certification

    In March 2025, GWOXI stem cell-derived exosomes obtained INCI Name certification as "Human Adipose-derived Mesenchymal Stem Cell Exosomes." This designation provides a clearer confirmation of their purity and efficacy, compared to the general term "Extracellular Vesicles." Additionally, GWOXI's stem cell sources meet clinical standards, with exosomes secreted by adipose-derived mesenchymal stem cells, which comply with international ICH guidelines. These exosomes can be used not only in cosmetic products but also in the development of new clinical drugs, representing pharmaceutical-grade raw materials. The certification from the Personal Care Products Council (PCPC) under the INCI Name system marks the first step toward international recognition of the raw material, confirming its safety and effectiveness. This milestone will help expand the market and serve as a significant growth driver for upcoming orders in GWOXI's CDMO division.

     
     
     

Press Releases

Press Releases
媒體報導
  • /userfiles/images/news/250704/20250729022827101.jpg
    04
    2025
    07
    Press Releases
    GWOXI Stem Cell Enters Japan to Expand International Regenerative Medicine Business, Pushing to Internationalize Adipose Stem Ce

  • /userfiles/images/news/250616/20250729030622724.jpg
    16
    2025
    06
    Press Releases
    GWOXI Stem Cell Makes a Preemptive Strategic Move to Address the Dual Challenges of Population Aging and Younger-Onset Stroke.

  • /userfiles/images/news/250513/20250729032057439.jpg
    13
    2025
    05
    Press Releases
    GWOXI's New Stem Cell Drug for Osteoarthritis Approved to Start a Phase III Clinical Trial in Taiwan.